Abivax Sa ADR (ABVX)
7.00 x 10 7.64 x 3
Pre-market by (Cboe BZX)
7.12 -0.14 (-1.93%) 04/29/25 [NASDAQ]
7.00 x 10 7.64 x 3
Pre-market 7.12 unch (unch) 16:00 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | ABVX | PGEN | ETON | ||
Company | Abivax Sa ADR | Precigen Inc | Eton Pharmaceutcials Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 7.03 | 1.5400 | 15.81 | ||
High | 7.42 | 1.6100 | 16.49 | ||
Low | 7.03 | 1.5200 | 15.57 | ||
Last | 7.12 | 1.5400 | 16.49 | ||
Change | -0.14 | -0.0100 | +0.51 | ||
% Change | -1.93% | -0.65% | +3.19% | ||
Volume | 47,600 | 1,331,100 | 251,200 | ||
20-Day Average Volume | 144,540 | 1,414,510 | 253,410 | ||
Previous Close | 7.26 | 1.5500 | 15.98 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 6.16 | 1.4182 | 13.80 | ||
20-Day Raw Stochastic | 73.44% | 79.63% | 87.53% | ||
20-Day Relative Strength | 56.50% | 50.81% | 62.54% | ||
Weighted Alpha | -47.58 | -20.36 | +328.36 | ||
Today's Opinion | 48% Sell | 56% Buy | 56% Buy | ||
Previous Opinion | 48% Sell | 56% Buy | 56% Buy | ||
Last Month's Opinion | 88% Sell | 56% Buy | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +9.54% since 04/22/25 | +0.65% since 04/22/25 | +9.64% since 04/22/25 | ||
Low | 6.75 on 04/23/25 | 1.4800 on 04/25/25 | 15.19 on 04/23/25 | ||
High | 7.97 on 04/23/25 | 1.6500 on 04/23/25 | 17.26 on 04/28/25 | ||
1-Month | |||||
%Chg | +10.73% since 03/28/25 | -3.14% since 03/28/25 | +26.65% since 03/28/25 | ||
Low | 4.77 on 04/09/25 | 1.1100 on 04/07/25 | 11.09 on 04/07/25 | ||
High | 7.97 on 04/23/25 | 1.6500 on 04/23/25 | 17.26 on 04/28/25 | ||
3-Month | |||||
%Chg | +21.29% since 01/29/25 | +18.46% since 01/29/25 | -3.40% since 01/29/25 | ||
Low | 4.77 on 04/09/25 | 1.1100 on 04/07/25 | 11.09 on 04/07/25 | ||
High | 8.47 on 03/06/25 | 2.1700 on 02/18/25 | 18.41 on 02/05/25 | ||
6-Month | |||||
%Chg | -32.83% since 10/29/24 | +82.77% since 10/29/24 | +93.09% since 10/29/24 | ||
Low | 4.77 on 04/09/25 | 0.6513 on 12/16/24 | 8.24 on 11/04/24 | ||
High | 11.02 on 11/04/24 | 2.1700 on 02/18/25 | 18.41 on 02/05/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 451,543 | 452,826 | 442,229 | ||
Shares Outstanding, K | 63,419 | 294,043 | 26,818 | ||
Annual Sales | 0 | 3,930,000 | 39,010,000 | ||
Annual Net Income | -190,710,000 | -126,240,000 | -3,820,000 | ||
Last Quarter Sales | N/A | 1,190,000 | 11,650,000 | ||
Last Quarter Net Income | N/A | -19,730,000 | -600,000 | ||
60-Month Beta | 0.45 | 1.70 | 1.34 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.04 on 03/19/25 | -0.02 on 03/18/25 | ||
Latest Earnings Date | 03/24/25 | 05/13/25 | 05/08/25 | ||
Most Recent Dividend | N/A | 0.162 on 06/09/15 | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |